Marine n-3 fatty acids are incorporated into atrial tissue but do not correlate with postoperative atrial fibrillation in cardiac surgery

Vascul Pharmacol. 2016 Dec:87:70-75. doi: 10.1016/j.vph.2016.11.004. Epub 2016 Nov 17.

Abstract

Objectives: Postoperative new-onset atrial fibrillation (POAF) in cardiac surgery is associated with increased morbidity and mortality. Because n-3 polyunsaturated fatty acids (n-3 PUFA) have an antiarrhythmic effect, we hypothesized that a high content of marine n-3 PUFA in the atrial wall was associated with a reduced risk of POAF.

Design: Venous blood and tissue from the right atrial appendage were obtained from 50 patients undergoing elective cardiac surgery. We determined the content of marine n-3 PUFA in atrial tissue and in plasma phospholipids using gas chromatography.

Results: The mean age of the patients (results available from 49 patients) was 66.0±10.4years, and 22, 14, 10 and 3 patients underwent coronary artery bypass surgery, valve, combined or other cardiac surgery, respectively. Eighteen patients (36.7%) developed POAF. Concentrations of n-3 PUFA in the atrial wall and in plasma phospholipids did not predict the development of POAF, but there were significant correlations between marine n-3 PUFA in atrial tissue and plasma.

Conclusion: Levels of marine n-3 PUFA in the atrial wall was not associated with the risk of POAF following cardiac surgery, despite significant correlations of marine n-3 PUFA in the atrium and in plasma phospholipids.

Keywords: Atrial tissue; Cardiac surgery; Marine fatty acids; Plasma phospholipids; Postoperative atrial fibrillation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Atrial Fibrillation / blood*
  • Atrial Fibrillation / epidemiology
  • Cardiac Surgical Procedures
  • Case-Control Studies
  • Chromatography, Gas
  • Coronary Artery Bypass
  • Fatty Acids, Omega-3 / blood*
  • Female
  • Heart Atria / metabolism*
  • Humans
  • Male
  • Middle Aged
  • Phospholipids / blood
  • Postoperative Complications / blood*
  • Postoperative Complications / epidemiology

Substances

  • Fatty Acids, Omega-3
  • Phospholipids